These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 25263393

  • 1. Effects of multiple-dose rifampicin 450 mg on the pharmacokinetics of fexofenadine enantiomers in Japanese volunteers.
    Akamine Y, Miura M, Yasui-Furukori N, Ieiri I, Uno T.
    J Clin Pharm Ther; 2015 Feb; 40(1):98-103. PubMed ID: 25263393
    [Abstract] [Full Text] [Related]

  • 2. An update on the clinical pharmacokinetics of fexofenadine enantiomers.
    Akamine Y, Miura M.
    Expert Opin Drug Metab Toxicol; 2018 Apr; 14(4):429-434. PubMed ID: 29635947
    [Abstract] [Full Text] [Related]

  • 3. [Determinants of the stereoselective pharmacokinetics of fexofenadine].
    Akamine Y.
    Yakugaku Zasshi; 2015 Apr; 135(3):473-81. PubMed ID: 25759055
    [Abstract] [Full Text] [Related]

  • 4. The change of pharmacokinetics of fexofenadine enantiomers through the single and simultaneous grapefruit juice ingestion.
    Akamine Y, Miura M, Komori H, Tamai I, Ieiri I, Yasui-Furukori N, Uno T.
    Drug Metab Pharmacokinet; 2015 Oct; 30(5):352-7. PubMed ID: 26213156
    [Abstract] [Full Text] [Related]

  • 5. Effect of coadministration of single and multiple doses of rifampicin on the pharmacokinetics of fexofenadine enantiomers in healthy subjects.
    Kusuhara H, Miura M, Yasui-Furukori N, Yoshida K, Akamine Y, Yokochi M, Fukizawa S, Ikejiri K, Kanamitsu K, Uno T, Sugiyama Y.
    Drug Metab Dispos; 2013 Jan; 41(1):206-13. PubMed ID: 23115085
    [Abstract] [Full Text] [Related]

  • 6. The different effects of itraconazole on the pharmacokinetics of fexofenadine enantiomers.
    Tateishi T, Miura M, Suzuki T, Uno T.
    Br J Clin Pharmacol; 2008 May; 65(5):693-700. PubMed ID: 18294330
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of fexofenadine enantiomers in healthy subjects.
    Miura M, Uno T, Tateishi T, Suzuki T.
    Chirality; 2007 Mar; 19(3):223-7. PubMed ID: 17230498
    [Abstract] [Full Text] [Related]

  • 8. Different effects of three transporting inhibitors, verapamil, cimetidine, and probenecid, on fexofenadine pharmacokinetics.
    Yasui-Furukori N, Uno T, Sugawara K, Tateishi T.
    Clin Pharmacol Ther; 2005 Jan; 77(1):17-23. PubMed ID: 15637527
    [Abstract] [Full Text] [Related]

  • 9. Influence of drug-transporter polymorphisms on the pharmacokinetics of fexofenadine enantiomers.
    Akamine Y, Miura M, Sunagawa S, Kagaya H, Yasui-Furukori N, Uno T.
    Xenobiotica; 2010 Nov; 40(11):782-9. PubMed ID: 20839930
    [Abstract] [Full Text] [Related]

  • 10. Carbamazepine differentially affects the pharmacokinetics of fexofenadine enantiomers.
    Akamine Y, Miura M, Yasui-Furukori N, Kojima M, Uno T.
    Br J Clin Pharmacol; 2012 Mar; 73(3):478-81. PubMed ID: 21950458
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics, pharmacodynamics, and tolerance of single- and multiple-dose fexofenadine hydrochloride in healthy male volunteers.
    Russell T, Stoltz M, Weir S.
    Clin Pharmacol Ther; 1998 Dec; 64(6):612-21. PubMed ID: 9871426
    [Abstract] [Full Text] [Related]

  • 13. Effects of one-time apple juice ingestion on the pharmacokinetics of fexofenadine enantiomers.
    Akamine Y, Miura M, Komori H, Saito S, Kusuhara H, Tamai I, Ieiri I, Uno T, Yasui-Furukori N.
    Eur J Clin Pharmacol; 2014 Sep; 70(9):1087-95. PubMed ID: 24903351
    [Abstract] [Full Text] [Related]

  • 14. Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine.
    Dresser GK, Bailey DG, Leake BF, Schwarz UI, Dawson PA, Freeman DJ, Kim RB.
    Clin Pharmacol Ther; 2002 Jan; 71(1):11-20. PubMed ID: 11823753
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of fexofenadine: evaluation of a microdose and assessment of absolute oral bioavailability.
    Lappin G, Shishikura Y, Jochemsen R, Weaver RJ, Gesson C, Houston B, Oosterhuis B, Bjerrum OJ, Rowland M, Garner C.
    Eur J Pharm Sci; 2010 May 12; 40(2):125-31. PubMed ID: 20307657
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Enantioselective disposition of fexofenadine with the P-glycoprotein inhibitor verapamil.
    Sakugawa T, Miura M, Hokama N, Suzuki T, Tateishi T, Uno T.
    Br J Clin Pharmacol; 2009 May 12; 67(5):535-40. PubMed ID: 19552748
    [Abstract] [Full Text] [Related]

  • 18. Effect of itraconazole on the pharmacokinetics and pharmacodynamics of fexofenadine in relation to the MDR1 genetic polymorphism.
    Shon JH, Yoon YR, Hong WS, Nguyen PM, Lee SS, Choi YG, Cha IJ, Shin JG.
    Clin Pharmacol Ther; 2005 Aug 12; 78(2):191-201. PubMed ID: 16084853
    [Abstract] [Full Text] [Related]

  • 19. Clinical pharmacokinetics of fexofenadine enantiomers.
    Miura M, Uno T.
    Expert Opin Drug Metab Toxicol; 2010 Jan 12; 6(1):69-74. PubMed ID: 19947891
    [Abstract] [Full Text] [Related]

  • 20. Lack of dose-dependent effects of itraconazole on the pharmacokinetic interaction with fexofenadine.
    Uno T, Shimizu M, Sugawara K, Tateishi T.
    Drug Metab Dispos; 2006 Nov 12; 34(11):1875-9. PubMed ID: 16928786
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.